Incidence of Tuberculosis in India and Global Regions
Journal Selection & Submission Sample Work
Tuberculosis (TB) is a serious infectious disease caused by Mycobacterium tuberculosis.
India bears the highest TB burden globally, accounting for about 27% of cases.
TB remains a leading cause of death worldwide, especially in low-income regions.
Efforts are ongoing to control and eliminate TB through early detection and treatment.
Tuberculosis incidence in India and the wider world: the manuscript's scope
Tuberculosis, caused by Mycobacterium tuberculosis, remains one of the leading infectious causes of death worldwide. Its incidence is shaped by poverty, crowding, undernutrition, HIV co-infection, diabetes and access to diagnosis and treatment, and drug-resistant forms complicate control. India carries the largest national share of the global burden: the sample's own appendix gives a figure of about 27% of the world's TB cases and roughly 2.5 million cases a year, and notes that the Revised National Tuberculosis Control Programme has become the National TB Elimination Programme, with an emphasis on early diagnosis, improved regimens and public awareness.
The manuscript behind this report, Incidence of Tuberculosis in India and Global Regions, compares these patterns. Incidence analyses draw on notification data, prevalence surveys and modelled estimates, each with different strengths, and comparisons across regions require care about which source is used. The journal selection report looks for journals whose readers work on TB epidemiology and control programmes.
Three journals devoted to tuberculosis
Unlike most reports, which mix specialist and general titles, this shortlist is made up entirely of TB-focused journals.
- International Journal of Tuberculosis and Lung Disease (IJTLD), published by The International Union Against Tuberculosis and Lung Disease, is described as a leading journal in TB and lung disease with a multidisciplinary approach and influence on public-health policy. The report highlights that it offers free publication for authors, mainly in low- and middle-income countries, who lack open-access funding. Its scope runs from clinical studies and epidemiology to drug resistance, social and behavioural aspects and health policy.
- Frontiers in Tuberculosis (Frontiers Media SA) is an open-access journal for interdisciplinary TB research, covering basic and translational work, diagnosis and treatment, epidemiology and drug-resistant TB, and innovative diagnostics.
- Journal of Clinical Tuberculosis and Other Mycobacterial Diseases (JCTUBE, Elsevier) publishes clinically relevant articles on TB and other mycobacterial infections, with stated emphasis on epidemiology and clinical investigation. Its examples include a 2025 paper on therapeutic thresholds in TB care drawing on Southern African experience.
What the comparator records on length, cost and indexing
The details below are as reported in the sample; impact factors and charges change over time and should be confirmed with each journal.
| Parameter | IJTLD | Front Tuberc | JCTUBE |
|---|---|---|---|
| Impact factor | 1.222 | 3.4 | 2.0 |
| Review duration | 8 weeks | 77–90 days | not specified |
| APC | free for eligible authors (a small fee range is also listed) | depends on article type and length | USD 2,610 excluding taxes |
| Word count | about 2,500 (original articles) | 12,000 (original research and reviews); 4,000 (brief research reports) | 3,000 (original research) |
| Figures/tables | up to 7 (original articles and reviews) | 15 recommended | up to 5 |
Indexing differs noticeably: the IJTLD is listed in MEDLINE, PubMed, Scopus, Embase and Web of Science, while the other two are listed mainly in PubMed Central, DOAJ and related services. For authors whose institutions assess outputs by MEDLINE or Web of Science coverage, that difference may outweigh the impact factor. Several rate fields in this comparator are incomplete or contain values that do not fit the column, so acceptance statistics should be sought from the journals directly.
Choosing a TB journal for an India–global comparison
The IJTLD's free-to-publish route and its readership among national TB programmes make it a strong first choice for a paper whose value lies in policy relevance, though its approximately 2,500-word limit for original articles requires a disciplined presentation of regional data. Frontiers in Tuberculosis allows much longer articles and more figures, useful if the comparison spans many regions and years. JCTUBE suits a paper with a clinical-epidemiology emphasis and accepts thematic reviews.
Incidence comparisons are judged on transparency about data sources. Authors should state whether figures come from notifications, surveys or modelled estimates such as those in global TB reports, how under-reporting was handled, and which years are compared. Observational analyses should follow STROBE; pooled estimates from multiple studies call for systematic review methods, which Pubrica supports through its meta-analysis service.
Lessons for preparing your own journal selection brief
This sample's job sheet places a descriptive sentence about TB incidence where keywords would normally go. Real keywords — for example tuberculosis, incidence, India, global burden, drug-resistant TB, TB control — work better, because they drive the search for comparable published articles and help editors classify the manuscript. When adapting the format, also confirm that every example article cited for a journal was actually published in that journal. Pubrica's journal selection service prepares checked shortlists of this kind, and journal submission support handles the next stage.
Questions about this sample
Why does the TB report recommend only tuberculosis-specific journals?
The manuscript compares tuberculosis incidence in India and other regions, a topic read most closely by TB researchers and national control programmes. The International Journal of Tuberculosis and Lung Disease, Frontiers in Tuberculosis and JCTUBE all focus on TB, so each offers a specialist readership rather than a general infectious-disease audience.
Is the International Journal of Tuberculosis and Lung Disease free to publish in?
The report states that it offers free publication for authors, mainly in low- and middle-income countries, who lack open-access funding. Its comparator also lists a small fee range, so authors should check the current policy and their eligibility on the journal's website before submission.
What TB figures for India does the sample give?
The appendix states that India accounts for about 27 percent of the world's TB cases, with roughly 2.5 million cases annually and significant regional variation. These figures are as reported in the sample; authors should cite the latest official sources, such as national programme reports or global TB reports, in their own manuscripts.
Which journal allows the longest manuscript for a regional comparison?
Frontiers in Tuberculosis. As reported in the sample, original research and review articles can run to 12,000 words with about 15 figures or tables recommended. The IJTLD limits original articles to about 2,500 words and JCTUBE to 3,000 words, which would require a more concise presentation.
Give yourself the academic edge today
Each order includes
- On-time delivery or your money back
- A fully qualified writer in your subject
- In-depth proofreading by our Quality Control Team
- 100% confidentiality, the work is never re-sold or published
- Standard 7-day amendment period
- A paper written to the standard ordered
- A detailed plagiarism report
- A comprehensive quality report
Enquire Now
